Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH2 | P05091 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.46 |
| ▸ | EYA3 | Q99504 | 2/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CDK9 | P50750 | 1/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL183071 | 1.00 | ALDH2 (0.52) | ALDH2KDM4EALDH1A1HPGDMAPT | |
| SCHEMBL6719113 | 0.82 | MAOA (0.61) | ALDH2KDM4EALDH1A1HPGDMAPT | |
| SCHEMBL4741002 | 0.76 | SMN1; SMN2 (0.48) | KDM4EALDH1A1HPGDMAPTSMN1; SMN2 | |
| SCHEMBL9072996 | 0.76 | CYP2C19 (0.43) | ALDH2KDM4EALDH1A1HPGDMAPT | |
| SCHEMBL4449379 | 0.76 | KDM4E (0.46) | KDM4EALDH1A1HPGDMAPTSMN1; SMN2 | |
| SCHEMBL744133 | 0.76 | KDM4E (0.60) | KDM4EALDH1A1MAPTSMN1; SMN2CYP3A4 | |
| SCHEMBL14619932 | 0.76 | CYP2C19 (0.43) | ALDH2KDM4EALDH1A1HPGDMAPT | |
| SCHEMBL17994122 | 0.76 | KDM4E (0.55) | KDM4EALDH1A1HPGDMAPTSMN1; SMN2 | |
| SCHEMBL20657033 | 0.76 | KDM4E (0.55) | KDM4EALDH1A1HPGDMAPTSMN1; SMN2 | |
| SCHEMBL19088878 | 0.76 | KDM4E (0.46) | KDM4EALDH1A1HPGDMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4076453-A1 | A PHARMACEUTICAL ORAL DOSAGE FORM OF Q203 | Qurient Co. Ltd. (KR) | 2022-10-26 | — | — | EP | claimed |
| EP-4676944-A1 | PHARMACEUTICAL FORMULATION COMPRISING HETERODIMERIC RELAXIN FUSION PROTEINS AND USES THEREOF | Astrazeneca AB (SE) | 2026-01-14 | — | — | EP | disclosed |
| EP-4525833-A2 | VETERINARY PHARMACEUTICAL FORMULATIONS | Increvet, Inc. (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2024242735-A1 | METHOD FOR MANUFACTURING PHARMACEUTICAL MINI-TABLETS | PURDUE RESEARCH FOUNDATION (US) | 2024-11-28 | — | — | WO | disclosed |
| EP-4429644-A1 | COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | ModernaTX, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| WO-2024184206-A1 | PHARMACEUTICAL FORMULATION COMPRISING HETERODIMERIC RELAXIN FUSION PROTEINS AND USES THEREOF | ASTRAZENECA AB (SE) | 2024-09-12 | — | — | WO | disclosed |
| WO-2023086465-A9 | COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | MODERNATX, INC. (US) | 2024-08-22 | — | — | WO | disclosed |
| WO-2024050310-A1 | LIPID-COATED NANOPARTICLES | SORRENTO THERAPEUTICS, INC. (US) | 2024-03-07 | — | — | WO | disclosed |
| WO-2023225492-A2 | VETERINARY PHARMACEUTICAL FORMULATIONS | INCREVET, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| WO-2023086465-A1 | COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | MODERNATX, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| EP-4164675-A1 | SYSTEMS, DEVICES, COMPOSITIONS, AND METHODS FOR TREATING DIABETES | Abvance Therapeutics Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| EP-4076453-A1 | A PHARMACEUTICAL ORAL DOSAGE FORM OF Q203 | Qurient Co. Ltd. (KR) | 2022-10-26 | — | — | EP | disclosed |